Wang Fei, Xu Boming, Li Quanpeng, Zhang Xiuhua, Jiang Guobing, Ge Xianxiu, Nie Junjie, Zhang Xiuyun, Wu Ping, Ji Jie, Miao Lin
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Medicine (Baltimore). 2016 Dec;95(52):e5743. doi: 10.1097/MD.0000000000005743.
Endoscopic retrograde cholangiopancreatography (ERCP) in patients with surgically altered anatomy is challenging. Results of ERCP in those patients varied.The aim of our study was to evaluate the safety and effectiveness of various endoscopes-assisted ERCP in patients with surgically altered anatomy.Fifty-two patients with Billroth II reconstruction (group A), 20 patients with subtotal or total gastrectomy with Roux-en-Y anastomosis (group B), 25 patients with pancreatoduodenectomy or Roux-en-Y hepaticojejunostomy reconstruction (group C) were included. Gastroscope, duodenoscope, colonoscope, and double-balloon enteroscope were used.The endoscope insertion success rate of groups A, B, C was 96.2% (50/52), 85.0% (17/20), 80% (20/25), respectively. χ test showed that there was no significant difference between the 3 groups (P = 0.068). The mean insertion time was 36.7, 68.4, and 84.0 minutes, respectively. One-way ANOVA showed that the insertion time of group C was significantly longer than that of groups B and C (both P <0.001). The endoscopic cannulation success rates of groups A, B, C were 90%, 82.4%, and 100%, respectively. χ test showed that there was no significant difference between the 3 groups (P = 0.144). The mean cannulation time was 19.4, 28.1, and 20.4 minutes, respectively. One-way ANOVA showed that the cannulation time of group B was longer than that of groups A and C (P <0.001, P = 0.001, respectively). In total, 74 patients with successful biliary cannulation achieved the therapeutic goal; thus, the clinical success rate was 76.3% (74/97).Our study showed that ERCP in patients with surgically altered anatomy was safe and feasible.
对解剖结构已手术改变的患者进行内镜逆行胰胆管造影(ERCP)具有挑战性。这些患者的ERCP结果各不相同。我们研究的目的是评估各种内镜辅助ERCP在解剖结构已手术改变患者中的安全性和有效性。纳入了52例行毕Ⅱ式重建的患者(A组)、20例行胃大部切除术或全胃切除术并Roux-en-Y吻合术的患者(B组)、25例行胰十二指肠切除术或Roux-en-Y肝空肠吻合术重建的患者(C组)。使用了胃镜、十二指肠镜、结肠镜和双气囊小肠镜。A、B、C组的内镜插入成功率分别为96.2%(50/52)、85.0%(17/20)、80%(20/25)。χ检验显示3组之间无显著差异(P = 0.068)。平均插入时间分别为36.7、68.4和84.0分钟。单因素方差分析显示C组的插入时间显著长于A组和B组(P均<0.001)。A、B、C组的内镜插管成功率分别为90%、82.4%和100%。χ检验显示3组之间无显著差异(P = 0.144)。平均插管时间分别为19.4、28.1和20.4分钟。单因素方差分析显示B组的插管时间长于A组和C组(分别为P<0.001、P = 0.001)。总共有74例胆管插管成功的患者达到了治疗目标;因此,临床成功率为76.3%(74/97)。我们的研究表明,对解剖结构已手术改变的患者进行ERCP是安全可行的。